Built on thirty years of clinical research
Omega Care CAR-T is the international patient programme of the Omega ecosystem — bringing together clinical research heritage, licensed manufacturing and a national care network.
Omega
Founded in 1997 as Türkiye's first contract research organisation, Omega has run Phase I–IV and post-marketing studies for national and international projects, and has worked in the CAR-T field for more than eight years.
1997
founded
8+
years in CAR-T
Partnership
Our Partners
Strategic partners in cell and gene therapy, working together to advance treatment accessibility.
Hillgene
Cell therapy CDMO with 200+ cell products, 15+ successful IND filings, and EU QP compliance certification. Exclusive authorized distributor partner in Türkiye.
CellBri
Cell and gene therapy partner specializing in advanced cellular treatments and regenerative medicine solutions.
UniCar
CAR-T cell therapy and immunotherapy partner, bringing cutting-edge immune-based cancer treatments to patients.
Ecosystem
Our Ecosystem Companies
The Omega ecosystem spans biotechnology, diagnostics, health services and specialized medical products.
Omega Bio
Biomedical research and development, advancing scientific innovation in life sciences.
Synbiyotik
Biotechnology company specializing in proprietary molecular tools, expression platforms (CHO, Pichia, E. coli), recombinant proteins, mRNA products, and cell line development services.
Bioligo
Oligonucleotide synthesis and genetic analysis, supporting precision medicine applications.
Spinex
Health technology company at ODTÜ TEKNOKENT developing digital health platforms, medical IoT, wearable devices (ECG patch, CGM, smart band), and AI-powered remote patient monitoring systems.
Omega Pharmaceutical Warehouse
Pharmaceutical wholesale and distribution, ensuring reliable supply chain for medical products.